46
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Predictive value and utility of oral steroid testing for treatment of COPD in primary care: the COOPT study

, , , , , , & show all
Pages 431-436 | Published online: 19 Nov 2009

References

  • RabeKFHurdSAnzuetoAGlobal Initiative for Chronic Obstructive Lung DiseaseGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2007176653255517507545
  • BurgePSCalverleyPMJonesPWRandomised double blinded placebo-controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: The ISOLDE trialBMJ20003201297130310807619
  • PauwelsRALofdahlCGLaitinenLALong-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary DiseaseN Engl J Med19993401948195310379018
  • HerlandKAkselsenJPSkjonsbergOHBjermerLHow representative are clinical study patients with asthma or COPD for a larger “real life” population of patients with obstructive lung diseaseRespir Med200599111915672843
  • The Lung Health Study Research GroupEffects of inhaled triam-cinolone on the decline in pulmonary function in chronic obstructive pulmonary diseaseN Engl J Med20003431902190911136260
  • VestboJSorensenTLangePLong-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: A randomised controlled trialLancet19993531819182310359405
  • CalverleyPMAInhaled corticosteroids are beneficial in chronic obstructive pulmonary diseaseAm J Resp Crit Care Med200016134134210673165
  • NisarMWalshawMEarisJEPearsonMGCalverleyPMAssessment of reversibility of airways obstruction in patients with chronic obstructive airways diseaseThorax1990451901942330551
  • BarnesPJInhaled corticosteroids are not beneficial in chronic obstructive pulmonary diseaseAm J Resp Crit Care Med200016134234410673166
  • ChanezPVignolaAMO’ShaugnessyTCorticosteroid reversibility in COPD is related to features of asthmaAm J Resp Crit Care Med1997155152915349154853
  • SchayckCPvan GrunsvenPMDekhuijzenPNRDo patients with COPD benefit from treatment with inhaled corticosteroidsEur Respir J19969196919728902451
  • CallahanCMDittusRSKatzBPOral corticosteroid therapy for patients with stable chronic obstructive pulmonary disease: a meta-analysisAnn Intern Med19911142162231824614
  • SiafakasNMVermeirePPrideNBOptimal assessment and management of chronic obstructive pulmonary disease (COPD). ERS consensus statementEur Respir J19958139814207489808
  • American Thoracic SocietyStandards for the diagnosis and care of patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med1995152S77S1207582322
  • The COPD Guidelines Group of the Standards of Care Committee of the BTSBTS Guidelines for the management of chronic obstructive pulmonary diseaseThorax199752S5S1S28
  • WeirDCGroveRIRobertsonASBurgePSCorticosteroid trials in non-asthmatic chronic airflow obstruction: a comparison of oral prednison and inhaled beclomethasone dipropionateThorax1990451121172180105
  • KoyamaHNishimuraKMioTIzumiTResponse to oral corticosteroid in patients with chronic obstructive pulmonary diseaseIntern Med199231117911841286223
  • WeinerPWeinerMRabnerMWaizmanJMagadleRZamirDThe response to inhaled and oral steroids in patients with stable chronic obstructive airway diseaseJ Intern Med1999245838910095821
  • DaviesLNisarMPearsonMGCostelloRWEarisJECalverleyPMAOral corticosteroid trials in the management of stable chronic obstructive pulmonary diseaseQ J Med199992395400
  • ChavannesNHSchermerTRJon behalf of the COOPT Study GroupLong-term inhaled steroid response testing should be done in heterogeneous COPD-populationThorax200358648
  • BurgePSCalverleyPMAJonesPWSpencerSAndersonJAon behalf of the Isolde Study GroupPrednisolone response in patients with chronic obstructive pulmonary disease: results from the ISOLDE studyThorax20035865465812885977
  • SchermerTChavannesNDekhuijzenRFluticasone and N-acetylcysteine in primary care patients with COPD or chronic bronchitisRespir Med2009103454255119138505
  • GuyattGHBermanLBTownsendMPugsleySOChambersLWA measure of quality of life for clinical trials in chronic lung diseaseThorax1987427737783321537
  • CelliBRMacNeeWAgustiAStandards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paperEur Respir J20042393294615219010
  • National Institute for Clinical Excellence (NICE)Chronic obstructive pulmonary disease. National clinical guideline for management of chronic obstructive pulmonary disease in adults in primary and secondary careThorax200459Suppl 11232
  • DigglePJLiangKYZegerSLAnalysis of Longitudinal DataOxford, UKOxford University Press1994
  • TwiskJWRApplied Longitudinal Data Analysis for EpidemiologyCambridge, UKCambridge University Press2003
  • SchermerTRHendriksAJChavannesNHProbability and determinants of relapse after discontinuation of inhaled corticosteroids in patients with COPD treated in general practicePrim Care Respir J200413485516701637
  • PrescottEBjergAMAndersenPKGender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population studyEur Respir J1997108228279150319
  • GrossNJResponses to steroids and bronchodilators in COPD in the ISOLDE trial: the fat lady sings onThorax20035864764812885972